We recently published Jim Cramer Discussed These 12 Stocks & Wondered Whether He Should Melt Silver.  Honeywell International Inc. (NASDAQ:HON) is one of the stocks that Jim Cramer discussed. Industrial conglomerate Honeywell International Inc. (NASDAQ:HON)’s shares are up by 11.7% over the past year and by 19.4% year-to-date. JPMorgan increased the firm’s share price target to $255 from $218 and bumped the rating to Overweight from Neutral in January. At the core of the coverage was the bank’s opinion th ...

Company Overview - Booz Allen Hamilton Holding Corporation (NYSE:BAH) is one of the largest consulting firms globally [2] - The company's shares have decreased by 31% over the past year but have increased by 4% year-to-date [2] Recent Developments - The firm faced a setback when the Treasury Department terminated contracts due to a tax data leak, impacting approximately $4.8 million in annual revenue [2] - Despite this, Booz Allen Hamilton's total annual revenue stands at $11.41 billion, indicating that the lost contracts represent a small fraction of its overall income [2] Analyst Ratings and Price Targets - Truist maintained a Hold rating on Booz Allen Hamilton with a price target of $98 [2] - DA Davidson raised its price target for the stock from $73 to $81 while keeping a Neutral rating, citing increased earnings estimates for 2026 and 2027, now projected at $6.10 and $6.75 respectively [2] Market Commentary - Jim Cramer mentioned Booz Allen Hamilton positively after the firm reported earnings, noting a significant increase in stock price due to market factors [2] - There is a belief that while Booz Allen Hamilton has potential, some AI stocks may offer better returns with lower risk [3]

We recently published 10 Big Names Leaving Wall Street Behind; 7 Are Hitting Record Highs. Intel Corp. (NASDAQ:INTC) was one of the worst performers on Wednesday. Intel Corp. rallied to a new 52-week high on Wednesday, as investors loaded portfolios ahead of the results of its earnings performance for the full year and fourth quarter periods of 2025. At intra-day trading, the stock jumped to its highest price of $54.41, up 12 percent, before trimming gains to end the session just up by 11.74 percent at $ ...

Core Viewpoint - Pfizer Inc. (NYSE:PFE) is facing challenges with its stock performance, as shares are down 4.7% over the past year and flat year-to-date, with significant revenue at risk due to upcoming patent expirations [2] Group 1: Stock Performance and Analyst Ratings - Pfizer's shares have decreased by 4.7% over the past year and have remained flat year-to-date [2] - UBS initiated coverage with a Neutral rating and a $25 price target, citing $15 billion to $20 billion in revenue tied to drugs losing patent protection in the next three years [2] - BMO maintained an Outperform rating with a $30 price target, highlighting concerns over a potential 23% annual sales dip in Pfizer's coronavirus business, projecting sales to fall to $5 billion [2] Group 2: Drug Pipeline and Market Position - Pfizer is focusing on its drug pipeline, reporting positive data for its PADCEV drug for bladder cancer in combination with Merck's Keytruda [2] - Jim Cramer discussed Pfizer in the context of Health Secretary RFK Jr., indicating that the vaccine business is under scrutiny and suggesting that Pfizer's leadership may not be prepared for public challenges [2][3]

Group 1 - Retail stocks are identified as potential winners if levies are reduced or eliminated [1] - There has been a notable increase in retail stock prices in anticipation of these changes [1]

Markets are bracing for a potentially market-moving U.S. Supreme Court ruling this Friday on the legality of President Donald Trump’s sweeping tariffs. With traders warning of chaos and prediction markets heavily skewed toward a loss for Trump, Tom Lee, the veteran Wall Street strategist behind Fundstrat, is floating the opposite idea. Related: Billionaire investor says there’s no real exit from money printing Trump tariffs and Supreme Court decision The legal battle centers on tariffs imposed by Trump ...

We recently published 10 Stocks Powering Into 2026 With Explosive Gains. CleanSpark, Inc. (NASDAQ:CLSK) is one of the top performers on Friday. CleanSpark snapped a six-day losing streak on Friday, jumping 14.13 percent to close at $11.55 apiece as investors took heart from higher Bitcoin prices while repositioning portfolios ahead of its mining report for the December and full-year 2025 periods. After the US markets officially closed the trading week, investor funds shifted to Bitcoin, supporting the l ...

Group 1 - Paramount Skydance Corporation (NASDAQ: PSKY) is actively pursuing an acquisition of Warner Bros. Discovery, with the bid price increasing from $19 to $22.50 per share [2] - Recent reports suggest that Warner Bros. Discovery may consider Paramount's offer if it is raised to $30, while Paramount is contemplating legal action against Warner's management board [2] - Jim Cramer has recommended that Paramount should increase its bid to $34 per share, arguing that this price would be competitive and likely to secure the acquisition [3] Group 2 - There is a belief that while PSKY has investment potential, other AI stocks may offer higher returns with lower risk, indicating a competitive landscape for investment opportunities [4]

Core Viewpoint - Affirm Holdings, Inc. (NASDAQ:AFRM) is experiencing a positive year-to-date performance with a 21% increase in share price, despite recent adjustments in price targets by analysts [2]. Group 1: Analyst Ratings and Price Targets - Bank of America has reduced its price target for Affirm Holdings from $98 to $97 while maintaining a Buy rating [2]. - Wolfe Research has initiated coverage on Affirm Holdings with a Peer Perform rating and a fair value range of $72 to $82 for year-end 2026 [2]. Group 2: Company Performance and Management Insights - The CFO of Affirm, Rob O'Hare, has addressed concerns regarding weak loan origination, attributing issues to tracking errors in the fourth quarter [2]. - Jim Cramer has expressed strong support for Affirm, stating that the company is having an "amazing quarter" and believes its stock has more potential for growth [3].

A stark new economic analysis reveals the Trump administration’s trade policies are extracting a heavy toll from Main Street, with small-business importers paying approximately $25,000 more per month in tariff costs since April 2025. The report, published Dec. 17 by the Center for American Progress (CAP), a left-wing think tank, details how a “chaotic approach” to trade and the elimination of key import exceptions have created a financial crisis for entrepreneurs during the critical holiday season. Accor ...